Quantcast HER2-Positive Breast Cancer Can Be Safely Treated With Trastuzumab And Adjuvant - Congoo
 
 
Log In
HER2-positive Breast Cancer can be Safely Treated With Trastuzumab and Adjuvant
Have an interest in this Story?
Sign Up for Real-Time email updates
MedIndia  | November 08, 2009

Category: Cancer News Font Size Researchers at Fox Chase Cancer Center report that it may be safe to treat these HER2-positive breast cancer patients with both Trastuzumab and adjuvant radiation therapy. The study will be presented today at the annual meeting of the American Society for Radiation O...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Martin P. Lee Martin P. Lee
Associate Lecturer
Knowledge Management
THENNY MEJIA THENNY MEJIA
Sr. Vice President
Healthcare Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.